Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses.
Meng Q, Valentini D, Rao M, Liu Z, Xie S, Morgell A, Dodoo E, L?hr M, Rangelova E, Del Chiaro M, Ernberg I, Maeurer M. Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses. Oncotarget. 2018 Apr 27; 9(32):22451-22459.